Who are we?

Solara Active Pharma Sciences offers Contract Research and Manufacturing and Development Services across the entire value chain of a new chemical entity which covers from Pre-Clinical to Commercial Phase. We have a strong team of 200+ scientists functioning from two research centers which are supported by a highly compliant manufacturing footprint spread over five large scale multi-product facilities.

R&D Centers
Manufacturing Sites
Successful USFDA audits across different sites
Years in the Industry

Why Solara?

Fragmented Supply Chain
Control Over Supply Chain for APIs
  • Comfort to customers with a backward integrated setup that ensures supply assurance of the key intermediates.

  • Diversified manufacturing base with mirrored capabilities for production

  • Scalable infrastructure to counter supply chain oversights going forward

Commitment to highest levels of Compliance
  • Integrated QMS from supply chain to product delivery to ensure consistent quality, efficacy and safety of products.

  • Last 2 USFDA audits cleared with zero 483s

One Stop Shop for your Chemical Needs
  • Offering services from mg to metric ton scale

  • We cover the entire life cycle of a new chemical entity at all scales, from pre-clinical and clinical phases to validation and commercial supply, while fully complying with HSE and cGMP regulations and standards within FDA and MHRA approved facilities.

  • Our experienced pool of scientists is backed by the state of the art research and development facilities and a strong network of five manufacturing sites.

Environment, Health and Safety
  • We comply with all applicable EHS Legal and other requirements

  • We optimize our resources in a way to prevent and reduce pollution, energy consumption and to increase water conservation.

Values – RITE

We at Solara respect our Employees, Customers and Partners. Here we ensure that our client’s expectations are consistently met.
Our business stands on the pillar of integrity, honesty and fairness. Everything we do here stands the test of public scrutiny.
Regularly engage with investors, suppliers, customers, and stakeholders by providing regular financial and business updates. Implemented rigorous disclosure and transparency norms in the organization.
Working towards achieving a high level of efficiency in all process and systems and fulfilling the promises made to stakeholders.

Leadership Team

Experienced Leadership & Experienced Team
Team member
Dr Sudhir Nambiar
Chief Scientific Officer
Dr Sudhir Nambiar comes with 25 years of experience in API Research & Development, spanning global majors and Indian pharma, both in the innovator and generic space. He has set up and led world class Process Research & Development (API) units in India for Novartis/Sandoz and AstraZeneca. He has been part of cross functional, multi-cultural teams that secured investments for these ventures and has a good understanding of both Indian and global pharmaceutical industry.
He was appointed as the Managing Director of AstraZeneca India Pvt Ltd in 2011 and under his leadership, the group contributed significantly to the process development of Tagrisso, a blockbuster NSCLC drug. Subsequently, he joined Dr Reddy’s Labs as Sr VP and Global Head, API, and developed generic drugs including complex generics. He further moved on as President, Research &Technology, Hikal Ltd, where in addition to generic APIs he developed Custom Pharmaceuticals, as well as Animal Health, Crop Protection and Chemical Specialty Agents. He also commercialized a few continuous and biocatalytic processes.